Statements (31)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
oral contraceptive
|
| gptkbp:activeIngredient |
gptkb:ethinyl_estradiol
norethindrone |
| gptkbp:alternativeName |
Norinyl 1+35
Norinyl 1+50 |
| gptkbp:ATCCode |
gptkb:G03AA05
|
| gptkbp:containsEstrogen |
gptkb:ethinyl_estradiol
|
| gptkbp:containsProgestin |
norethindrone
|
| gptkbp:contraindication |
gptkb:cancer
gptkb:liver_disease pregnancy history of thromboembolic disorders |
| gptkbp:countryOfOperation |
gptkb:United_States
|
| gptkbp:drugClass |
oral contraceptive
|
| gptkbp:estimatedStrength |
ethinyl estradiol 0.035 mg
ethinyl estradiol 0.05 mg norethindrone 1 mg |
| gptkbp:form |
gptkb:tablet
|
| https://www.w3.org/2000/01/rdf-schema#label |
Norinyl-20000
|
| gptkbp:legalStatus |
Rx-only
|
| gptkbp:marketedAs |
gptkb:Pfizer
|
| gptkbp:prescriptionStatus |
prescription only
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
nausea
headache breast tenderness mood changes weight gain |
| gptkbp:usedFor |
birth control
|
| gptkbp:bfsParent |
gptkb:mestranol
|
| gptkbp:bfsLayer |
8
|